Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Acta Neurobiol Exp (Wars) ; 78(2): 132-139, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30019704

RESUMEN

Muscarinic acetylcholine receptors (mAChR) are known to be related to learning and memory processes. Inactivation of mAChR by cholinergic antagonists have been shown to produce amnesia in a variety of behavioral tasks. In this study, we investigated the role of M1 and M2 AChR on passive avoidance learning and plasticity of synapses formed by Schaffer collaterals in freely moving rats. Experiments were performed using Wistar male rats. Seven days before testing, a recording electrode was lowered in the CA1 region under chloral hydrate anaesthesia to record the field excitatory postsynaptic potential (fEPSP) in response to Schaffer collateral stimulation. Selective M2 receptor antagonists methoctramine and selective M1 receptors antagonist pirenzepine were intraperitoneally injected immediately after training. The effects on memory retention were examined using passive avoidance training. We measured latency of the first entry into a dark compartment of the chamber. fEPSP amplitude and slope ratio were measured before shock presentation, 90 min after the shock, and 24 hour after the shock. Methoctramine significantly impaired behavior in the passive avoidance test but pirenzepine did not induce any changes compared to control. Our results showed that pirenzepine but not methoctramine supressed the amplitude of fEPSPs. On the other hand, intracerebroventricular methoctramine administration impaired passive avoidance learning and increased the amplitude of fEPSP.


Asunto(s)
Reacción de Prevención/efectos de los fármacos , Hipocampo/efectos de los fármacos , Antagonistas Muscarínicos/farmacología , Sinapsis/efectos de los fármacos , Animales , Potenciales Postsinápticos Excitadores/efectos de los fármacos , Hipocampo/metabolismo , Masculino , Memoria/efectos de los fármacos , Memoria/fisiología , Ratas Wistar , Receptores Muscarínicos/efectos de los fármacos , Receptores Muscarínicos/metabolismo , Sinapsis/fisiología , Transmisión Sináptica/efectos de los fármacos
2.
Antioxid Redox Signal ; 13(9): 1297-307, 2010 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-20446771

RESUMEN

The goal of this study was to investigate the possible role of reactive oxygen species (ROS) in signaling, in modulation of the cytoskeleton, and in differentiation of fibroblasts. For this purpose, we have applied a novel mitochondria-targeted antioxidant: plastoquinone conjugated with decyltriphenylphosphonium (SkQ1). This antioxidant at nanomolar concentration prevented ROS accumulation and cell death induced by H(2)O(2) in fibroblasts. We found that scavenging of ROS produced by mitochondria activated the Rho/ROCK/LIMK signaling pathway that was followed by phosphorylation of cofilin and stabilization of actin stress fibers. The mitochondria-targeted antioxidant induced differentiation of human subcutaneous fibroblasts to myofibroblasts as revealed by expression of fibronectin isoform (EDA-FN) and smooth muscle actin (α-SMA). This effect was shown to be mediated by transforming growth factor ß1 (TGFß1), which was activated by matrix metalloprotease 9 (MMP9) in the culture medium. Scavenging of ROS stimulated secretion of MMP9 rather than its processing. The same effect was achieved by the nontargeted antioxidant Trolox at higher concentration, but the thiol antioxidant N-acetylcysteine (NAC) inhibited MMP activity and was not able to induce myofibroblast differentiation. The myofibroblast phenotype was supported due to autocrine TGFß1-dependent stimulation after removal of SkQ1. It is concluded that ROS scavenging in mitochondria induces TGFß1-dependent myofibroblast differentiation.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Miofibroblastos/citología , Miofibroblastos/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Acetilcisteína/metabolismo , Acetilcisteína/farmacología , Actinas/metabolismo , Actinas/farmacología , Antioxidantes/metabolismo , Antioxidantes/farmacología , Cromanos/farmacología , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Fibronectinas/metabolismo , Fibronectinas/farmacología , Humanos , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/farmacología , Mitocondrias/metabolismo , Músculo Liso/metabolismo , Fosforilación , Plastoquinona/análogos & derivados , Plastoquinona/metabolismo , Plastoquinona/farmacología , Especies Reactivas de Oxígeno/farmacología , Transducción de Señal/efectos de los fármacos , Factor de Crecimiento Transformador beta/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA